fangchinoline has been researched along with vincaleukoblastine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ben-David, Y; Chen, C; Fan, Y; Hu, S; Pan, W; Song, J; Wang, C; Yang, J | 1 |
1 other study(ies) available for fangchinoline and vincaleukoblastine
Article | Year |
---|---|
Fangchinoline derivatives induce cell cycle arrest and apoptosis in human leukemia cell lines via suppression of the PI3K/AKT and MAPK signaling pathway.
Topics: Antineoplastic Agents; Apoptosis; Benzylisoquinolines; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; MAP Kinase Signaling System; Molecular Structure; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |